Rapport Therapeutics (RAPP) Common Equity (2023 - 2026)
Rapport Therapeutics' Common Equity came in at $422.93 million for Q2 2026, up 60.5% from $263.51 million a year earlier but down 10.3% from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Common Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Rapport Therapeutics' Common Equity was $484.65 million, up 58.7% from FY2024.
- Going back by year, Common Equity was $305.43 million in FY2024 and -$25.63 million in FY2023.
- The five-year range for quarterly Common Equity is -$39.63 million (Q1 2024) to $511.62 million (Q3 2025).
- Year-over-year, Common Equity has increased for four consecutive quarters, with growth averaging 44.1% over the last five quarters.
- Business Quant data shows RAPP's Common Equity at $471.51 million (Q1 2026), $484.65 million (Q4 2025) and $511.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Rapport Therapeutics | 1.60 Bn | 1.60 Bn | - | 422.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 422.93 Mn |
| Mar 31, 2026 | 471.51 Mn |
| Dec 31, 2025 | 484.65 Mn |
| Sep 30, 2025 | 511.62 Mn |
| Jun 30, 2025 | 263.51 Mn |
| Mar 31, 2025 | 285.84 Mn |
| Dec 31, 2024 | 305.43 Mn |
| Sep 30, 2024 | 323.11 Mn |
| Jun 30, 2024 | 336.89 Mn |
| Mar 31, 2024 | -39.63 Mn |
| Dec 31, 2023 | -25.63 Mn |
| Sep 30, 2023 | -13.12 Mn |
| Jun 30, 2023 | -9.43 Mn |
API Access
Rapport Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();